Finance

Lists
Why is MDMA up 2.38%?
Dive Deeper
MDMA:CNSX
Pharmala Biotech Holdings Inc
CA$0.22
+2.38%
(+0.0050) 1D
Oct 9, 4:00:00 PM GMT-4  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for MDMA...
Open
CA$0.21
High
CA$0.22
Low
CA$0.20
Mkt. cap
23.35M
Avg. vol.
170.21K
Volume
51.30K
52-wk high
CA$0.33
52-wk low
CA$0.08
EPS
-CA$0.02
No. of employees
3
Open
CA$0.21
High
CA$0.22
Low
CA$0.20
Mkt. cap
23.35M
Avg. vol.
170.21K
Volume
51.30K
52-wk high
CA$0.33
52-wk low
CA$0.08
EPS
-CA$0.02
No. of employees
3
News stories
From web sources and news partners
About Pharmala Biotech Holdings Inc
CEO-
Employees3
Founded2021
HeadquartersToronto, Ontario, Canada
SectorBiotechnology
Websitepharmala.ca
Last report
Jul 29, 2026
Fiscal period
Q3 2026
- / -
Revenue / Est. (CAD)
513.23K / -
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in CAD
Loading Previous Earnings...
Revenue
Net income
All values in CAD
Aug 2025
Nov 2025
Feb 2026
May 2026
Revenue
267.38K
206.44K
280.58K
513.23K
Cost of goods sold
34.04K
34.84K
22.41K
174.69K
Cost of revenue
34.04K
34.84K
22.41K
174.69K
Research and development expenses
44.91K
41.10K
40.53K
44.91K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
404.68K
320.96K
367.29K
472.32K
Operating expense
553.47K
498.41K
559.82K
810.59K
Total operating expenses
587.50K
533.25K
582.22K
985.28K
Operating income
-320.13K
-326.81K
-301.64K
-472.05K
Other non operating income
-41.00K
-16.84K
-46.18K
-40.97K
EBT including unusual items
-361.13K
-409.70K
-337.70K
-499.76K
EBT excluding unusual items
-361.13K
-343.65K
-347.82K
-513.01K
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-361.13K
-409.70K
-337.70K
-499.76K
Net profit margin
-135.07%
-198.46%
-120.35%
-97.37%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
29.19K
29.76K
29.74K
30.02K
EBITDA
-306.98K
-313.10K
-287.95K
-458.08K
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps